The effects of psychostimulants on cognitive functions in individuals with attention-deficit hyperactivity disorder: A systematic review
- PMID: 35303614
- DOI: 10.1016/j.jpsychires.2022.03.018
The effects of psychostimulants on cognitive functions in individuals with attention-deficit hyperactivity disorder: A systematic review
Abstract
Background: Attention-deficit/hyperactivity disorder (ADHD) is associated with a broad range of deficits in cognitive functions which has significant implications for quality of life. Psychostimulants are demonstrated to improve symptoms of inattention and hyperactivity/impulsivity, however, their impact on cognition remains incompletely characterized. Herein, the aim of this systematic review is to synthesize the extant literature reporting on the effects of psychostimulants on cognitive function in individuals with ADHD.
Method: A systematic search of PubMed, Scopus, and Web of Science from inception to July 2021 was conducted. Additional studies were identified through Google Scholar and a manual search of the reference lists of relevant articles. Inclusion criteria were original studies that evaluated the cognitive function of individuals with ADHD taking psychostimulants drugs. We assessed the quality of the included papers using the Newcastle-Ottawa scale (NOS).
Results: A total of 10 studies involving 753 subjects with ADHD and 194 healthy controls were identified and eligible for inclusion. Nine studies evaluated the impact of methylphenidate on cognitive function and one study investigated the use of lisdexamfetamine. Results indicated that attentional deficits such as memory, vigilance, divided attention, phasic and tonic alertness, and focused attention were improved in ADHD patients treated with psychostimulants. The efficacy of psychostimulants in improving other domains of cognition remains inconclusive due to conflicting evidence or insignificant findings (ie. academic performance and executive function). Overall, results indicate that psychostimulants may improve only select domains of cognition (ie. memory and attention).
Conclusion: Psychostimulants are reported to improve several disparate aspects of cognition among individuals with ADHD. Further research is needed to better understand the complex relationships between cognition and behavior in ADHD, as well as the impact of medication on these distinct aspects of functioning. Further research is also needed to determine whether the pro-cognitive effect of stimulants would be transferable to other mental disorders.
Keywords: ADHD; Attention deficit hyperactivity disorder; Cognition; Depression; Executive function; Memory; Psychostimulants.
Copyright © 2022 Elsevier Ltd. All rights reserved.
Similar articles
-
Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders.Cochrane Database Syst Rev. 2018 Jun 26;6(6):CD007990. doi: 10.1002/14651858.CD007990.pub3. Cochrane Database Syst Rev. 2018. PMID: 29944175 Free PMC article.
-
Stimulant and non-stimulant drug therapy for people with attention deficit hyperactivity disorder and epilepsy.Cochrane Database Syst Rev. 2022 Jul 13;7(7):CD013136. doi: 10.1002/14651858.CD013136.pub2. Cochrane Database Syst Rev. 2022. PMID: 35844168 Free PMC article.
-
Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.Cochrane Database Syst Rev. 2018 May 9;5(5):CD012069. doi: 10.1002/14651858.CD012069.pub2. Cochrane Database Syst Rev. 2018. PMID: 29744873 Free PMC article.
-
A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents.Health Technol Assess. 2006 Jul;10(23):iii-iv, xiii-146. doi: 10.3310/hta10230. Health Technol Assess. 2006. PMID: 16796929
-
Interventions for preventing and ameliorating cognitive deficits in adults treated with cranial irradiation.Cochrane Database Syst Rev. 2022 Nov 25;11(11):CD011335. doi: 10.1002/14651858.CD011335.pub3. Cochrane Database Syst Rev. 2022. PMID: 36427235 Free PMC article.
Cited by
-
Adverse Childhood Experiences and Prescription Stimulant Use in Adults: A Systematic Review.Pharmacy (Basel). 2024 Mar 21;12(2):52. doi: 10.3390/pharmacy12020052. Pharmacy (Basel). 2024. PMID: 38525732 Free PMC article. Review.
-
Transdiagnostic Attentional Deficits Are Associated with Depressive and Externalizing Symptoms in Children and Adolescents with Neuropsychiatric Disorders.Arch Clin Neuropsychol. 2025 May 21;40(4):783-793. doi: 10.1093/arclin/acae103. Arch Clin Neuropsychol. 2025. PMID: 39540608
-
Methylphenidate (Ritalin) does not improve exam performance in an experimental setting.Psychopharmacology (Berl). 2025 Aug 5. doi: 10.1007/s00213-025-06864-1. Online ahead of print. Psychopharmacology (Berl). 2025. PMID: 40762809
-
Revving up possibilities: can psychostimulants enhance physical function in children with cerebral palsy?Pediatr Res. 2024 Apr;95(5):1184-1185. doi: 10.1038/s41390-023-03010-5. Epub 2024 Jan 2. Pediatr Res. 2024. PMID: 38167643 No abstract available.
-
Methylphenidate differentially alters corticostriatal connectivity after traumatic brain injury.Brain. 2025 Apr 3;148(4):1360-1373. doi: 10.1093/brain/awae334. Brain. 2025. PMID: 39432756 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical